baber/WOPTO huggingface dataset:
Patent NZ-537056-A (NZ)
Title: Methacrylate structural adhesive
Inventor: WEN WEIJAN
IPC: C09J111/00
Filed: 2003-04-22
Abstract: Several compositions for use as structural adhesives are disclosed. The compositions include a monomer component and a catalyst component. In one aspect, the monomer component includes a first elastomeric material of a block copolymer of styrene and isoprene, a second elastomeric material of a block copolymer of styrene and butadiene, and a cross-linked rubber of a copolymer of acrylonitrile and butadiene. In a second aspect, the monomer component includes a first elastomeric material of a block copolymer of styrene and butadiene, and a cross-linked rubber of a copolymer of acrylonitrile and butadiene. In another aspect, isophthalic acid is utilized as a polymerizable acid monomer in combination with a phosphate ester. In another aspect, the monomer component includes a cohesive failure mode promoter of rosin esters or of talc.
Patent NZ-537709-A (NZ)
Title: Sensitization of chemotherapeutic agent resistant neoplastic cells with oncolytic virus
Inventor: COFFEY MATTHEW C
IPC: A61K35/76
Filed: 2002-02-19
Abstract: Disclosed is the use of an oncolytic virus in the manufacture of a medicament for sensitizing a ras-activated neoplastic cell to a chemotherapeutic agent in a patient in need thereof. Also disclosed is the use wherein the medicament comprises two pharmaceutical formulations suitable for sequential or concurrent administration, one of which contains an oncolytic virus and other of which contains the chemotherapeutic agent. Further disclosed are methods for: sensitising a non-human ras-activated neoplastic cell to a chemotherapeutic agent; preventing a ras-activated neoplasm in a non-human subject from developing drug resistance to a chemotherapeutic agent; treating a non-human subject harbouring a ras-activated proliferative disorder wherein said subject comprises ras-activated neoplastic cells that are refractory ro a chemotherapeutic agent; preventing a ras-activated neoplasm in a non-human subject from developing drug resistance to a chemotherapeutic agent; and sensitising a ras-activated neoplastic cell ex vivo or in vitro to a chemotherapeutic agent. (62) Divided Out of 527399
Patent NZ-567985-A (NZ)
Title: Animal tags and method of manufacture
Inventor: HOWELL TODD MICHAEL
IPC: A01K11/00
Filed: 2008-05-02
Abstract: An animal tag is disclosed. The animal tag includes a flag portion, made of a substantially flexible material, and a substantially rigid portion attached to the flag that has at least first and second parts, where each of the first and second parts have respective first and second apertures. Each part is secured or securable together, where each part is located on opposite sides of the flag.
Patent NZ-570640-A (NZ)
Title: Automated tool for human assisted mining and capturing of precise results
Inventor: JONES SCOTT A
IPC: G06F17/30
Filed: 2007-01-12
Abstract: A method of performing a search and an apparatus adapted to assist a human searcher in the performance of this search and responsive to a user request are disclosed. The apparatus comprises a display device rendering a query window showing a search query of the user request; and at least two windows simultaneously showing search results for the search query from at least two search engines; and a ranked list of available search resources associated with a subject matter of the query; and a processor for submitting the search query of the user request to the at least two search engines, determining content of the query window, the at least two windows, and ranking the available search resources based on the subject matter of the query. A method of assisting a human searcher performing a search responsive to a user request and an apparatus assisting a human searcher performing this search are disclosed. The apparatus comprises a display device rendering a query window; a plurality of search engine selection controls for selecting search engines to activate with the query; a database device storing content associated with previous usage of search engines; and a processor ranking the search engines, determining an order of presentation of the search engine selection controls, rendering a selected media file, and receiving a search result created by the human searcher. The search engine selection controls represent the highest ranked search engines for the subject matter of the query. A method of human-assisted information mining including a human searcher responding to a search query and a system assisting a human searcher performing this search and responsive to a user request are disclosed. The system comprises a user device for submitting a request; a provider system for receiving the request, displaying a search result provided by a selected resource, requesting a media file identified by the search result and enabling a human provider to compile a response to the request based on a search performed by the human provider; a search system ranking search resources based on a keyword of the request, locating the selected resource to which a query associated with the request will be submitted, and recording information of the response formulated by the human provider; and a database for storing information related to the request and the response.
Patent NZ-578254-A (NZ)
Title: Package for containers
Inventor: REQUENA EMILI
IPC: B65D71/46
Filed: 2007-11-08
Abstract: A package is formed from a carton and containers extending through apertures in a bottom panel of the carton. First and second struts and a brace in the carton interior provide support for the containers accommodated within the carton. The struts fold up from the cut-out region of the apertures. The brace extends up in-between the apertures so as to divide the apertures into two rows. When secured in the apertures the containers are prevented from translational movement.
Patent NZ-587050-A (NZ)
Title: Compounds featuring a tricyclic group double bonded to a piperidine group, as an antihistamine
Inventor: HIGASHIURA KUNIHIKO
IPC: A61K31/381
Filed: 2008-11-20
Abstract: Disclosed is a piperidine derivative of formula (I), such as 4-(2-cyano-9,10-dihydro-1-thiabenzo[f]azulen-4-ylidene)-1-methylpiperidine hydrochloride and 4-(2-Bromo-9,10-dihydro-1-thiabenzo[f]azulen-4-ylidene)-1-methylpiperidine which has an antagonistic activity on a histamine receptor. Also disclosed is a pharmaceutical compound for treatment of bronchial asthma, allergic rhinitis, pollinosis, urticaria and atopic dermatitis.
Patent NZ-588896-A (NZ)
Title: Heterocyclic compounds and methods of use
Inventor: WRASIDLO WOLFGANG
IPC: A61K31/44
Filed: 2005-08-24
Abstract: The disclosure relates to heterocyclic compounds derived from benzotriazine, triazines, triazoles and oxadiazoles. Particularly disclosed are oxadiazol compounds of formula (B), an N-oxide, N,N'-dioxide, N,N',N"-trioxide, and a pharmaceutically acceptable salt thereof, wherein the variables are as defined in the specification. These compounds affect the mitogen activated protein kinase (MAPK) pathway, and are useful for treating various types of cancer such as alimentary/gastrointestinal tract cancer, colon cancer, liver cancer, skin cancer, breast cancer, ovarian cancer, prostate cancer, lymphoma, leukemia, kidney cancer, lung cancer, muscle cancer, bone cancer, bladder cancer or brain cancer. The methods of synthesis and of use of these heterocyclic compounds are also disclosed.
Patent NZ-589854-A (NZ)
Title: Method and apparatus for identifying dietary choices
Inventor: MORREALE SANDRA JEAN
IPC: G16H20/60
Filed: 2009-05-28
Abstract: 589854 A computer-implemented method and an apparatus for facilitating selection of desirable choices are disclosed. In the method relative scores are generated in a processing device for a first group of choices in response to results from a plurality of forced choice comparisons by a plurality of informed domain representatives. The plurality of forced choice comparisons each include a selection of one choice from a pair of choices and the selections form the results for generating the relative scores. At an input device, measurements of at least two characteristics of each of a second group of choices are received and in a computing device, predicted relative scores for the individual ones of the second group of choices are calculated using the measurements of the at least two characteristics of each of the second group of choices in a model of the relative scores of the first group of choices. The predicted relative scores to communicate the predicted relative scores to facilitate selection of desirable choices are outputted via an output device. Further disclosed is a computer-implemented method for assisting a person to maintain a predetermined diet. In this method a minimum and maximum relative score number effective for maintaining a predetermined diet over a period of time are determined in a processing device. A relative score number is calculated for each of a number of possible food serving choices by fitting at least two characteristics of the possible food serving choices to a model generated from results of a plurality of forced choice comparisons of sample food choices by a plurality of informed domain representatives. The plurality of forced choice comparisons each include a selection of one food choice from a pair of food choices and the selections form the results for generating the model. Food serving choices are identified in a computing device that will provide an aggregated total relative score number between the determined minimum and maximum relative score number; and a diet plan using the identified food serving choices to thereby assist the person to maintain the predetermined diet is outputted via an output device.
Patent NZ-590431-A (NZ)
Title: Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor
Inventor: DERYNCK MIKA K
IPC: A61P35/00
Filed: 2006-02-21
Abstract: Disclosed is the use of pertuzumab in the manufacture of a medicament for extending time to disease progression (TTP) or survival in a cancer patient, wherein the cancer is selected from the group consisting of gastric cancer, stomach cancer, ovarian cancer, peritoneal cancer, fallopian tube cancer, metastatic breast cancer (MBC), non-small cell lung cancer (NSCLC), prostate cancer, and colorectal cancer, and wherein the medicament further comprises a second therapeutic agent comprising trastuzumab.
Patent NZ-593810-A (NZ)
Title: Glucagon analogues
Inventor: MEIER EDDI
IPC: C07K14/605
Filed: 2008-12-15
Abstract: 593810 Discloses a compound having the formula R1-X-Z-R2 wherein the peptide has the formula HIS-SER-GLN-GLY-THR-PHE-THR-SER-ASP-THY-SER-LYS-TYR-LEU-ASP-SER-LYS-ALA-ALA-HIS-ASP-PHE-VAL-GLU-TRP-LEU-ARG-ALA and variations thereof. Also describes the use of the compound in preventing weight gain, promoting weight loss.
Patent NZ-594039-A (NZ)
Title: Method for moving loads using a sky line
Inventor: NEWMAN DARRYN ANTHONY
IPC: B65G9/00
Filed: 2011-07-13
Abstract: 594039 Methods of moving loads via a sky line from hills of land to sea are disclosed, typically for logging in areas difficult to otherwise access. A sky line 10 is run from relocatable upper anchor points along access tracks 25, and down to an underwater anchor 14, located on the water bed, that is also relocatable.
Patent NZ-595187-A (NZ)
Title: A fluid blasting apparatus where the front stem bearing is supported on the nozzle drive shaft and located eccentric to the rotation axis
Inventor: FLANAGAN MICHAEL
IPC: B08B3/02
Filed: 2010-02-17
Abstract: A fluid blasting apparatus 10 comprises a frame 12, a head assembly 14 supported by the frame 12, a drive mechanism mounted to the head assembly 14 and adapted to drive a nozzle drive shaft about a rotation axis, and a rotatable nozzle 30 comprising a stem 32 having a longitudinal axis, a proximal end in fluid communication with a high pressure fluid source and a distal end having a nozzle tip 34. The stem 32 is mounted to the head assembly 14 at the proximal end by a rear stem 32 bearing and between the proximal and distal ends by a front stem 32 bearing. The front stem 32 bearing is supported on the nozzle drive shaft and located eccentric relative to the rotation axis, such that the front stem 32 bearing rotates around a circular path during rotation of the nozzle drive shaft and where the longitudinal axis is oblique to the rotation axis and the path of the nozzle tip 34 generally describes a circle.
Patent NZ-599005-A (NZ)
Title: Targeting pax2 for the treatment of breast cancer
Inventor: DONALD CARLTON D
IPC: A61P35/00
Filed: 2010-02-19
Abstract: Disclosed the use of an antagonist of signal transducer and activator of transcription 3 (STAT3) in the manufacture of a medicament for the treatment of a breast condition, wherein the ER/PR status of a diseased tissue in said subject is ER+/PR+ and the PAX2-to-DEFB1 expression ratio is in said diseased breast tissue is increased compared to the PAX2-to-DEFB1 ratio in normal breast tissue.
Patent NZ-599227-A (NZ)
Title: Therapeutic agent for chronic pain
Inventor: NIWA SHIN-ICHI
IPC: C07D215/22
Filed: 2010-02-26
Abstract: 599227 Disclosed herein is the use of a therapeutic agent comprising aripiprazole in the treatment of chronic pain in a patient. In one embodiment the therapeutic agent is administered orally, intracutaneously, subcutaneously, or intraperitoneally in a dose of about 0.05 to 10 mg per kg of body weight per day.
Patent NZ-599700-A (NZ)
Title: Restraining belt for children in a shopping cart contained in a housing fastened to the trolley
Inventor: SONNENDORFER HORST
IPC: B62B3/14
Filed: 2010-10-27
Abstract: 599700 The invention relates to a restraining belt for children in a shopping cart, wherein the belt is located in a housing (1) that can be fastened on the shopping cart, wherein a fastening element (3) is provided by means of which a lattice bar (4) of the shopping cart can be enclosed in a U-shape and the fastening element (3) comprises clip-like protrusions (7) extending between the individual lattice bars (4) and said clip-like protrusions have grooves (7), and edges (2) of the housing (1) engage in said grooves (8).
Patent NZ-601079-A (NZ)
Title: Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
Inventor: PATSALIS PHILIPPOS C
IPC: C12Q1/68
Filed: 2011-01-26
Abstract: Disclosed is a method for prenatal diagnosis of trisomy 21 using a sample of maternal blood, the method comprising: a) in a sample of maternal blood, physically separating hypermethylated DNA from hypomethylated DNA, without chemically altering or enzymatically digesting the hypomethylated DNA or hypermethylated DNA, to obtain a hypermethylated DNA sample; b) in the hypermethylated DNA sample, determining levels of a plurality of differentially methylated regions (DMRs) to obtain a hypermethylation value for the hypermethylated DNA sample, wherein one of the DMRs comprises a region selected from base pairs 39279856-39280004 (SEQ ID NO: 33), base pairs 44161178-44161323 (SEQ ID NO: 34), base pairs 33320735-33320829 (SEQ ID NO: 36), base pairs 42189557-42189683 (SEQ ID NO: 37), base pairs 42355712-42355815 (SEQ ID NO: 38), base pairs 42357215-42357341 (SEQ ID NO: 39), base pairs 32268843-32268943 (SEQ ID NO: 42) and base pairs 37841284-37841411 (SEQ ID NO: 44); c) comparing the hypermethylation value of the hypermethylated DNA sample to a standardized reference hypermethylation value for said plurality of DMRs; and d) diagnosing trisomy 21 based on said comparison. Further disclosed is a kit comprising two or more nucleic acid compositions for determining levels of a plurality of differentially methylated regions on chromosome 21 as disclosed in the method above.
Patent NZ-606042-A (NZ)
Title: Process for the preparation of erlotinib and salts thereof
Inventor: GORE VINAYAK GOVIND
IPC: C07D239/94
Filed: 2011-07-22
Abstract: Disclosed is a process for the preparation of a salt of erlotinib (particularly the hydrochloride salt), comprising reacting 4-chloro-6,7-bis-(2-methoxyethoxy)quinazoline and 3-ethynylaniline in methanol, wherein the reaction mixture does not contain an external acid or base. Also disclosed is a process for the preparation of erlotinib base, comprising reacting a salt of erlotinib (such as the hydrochloride salt) with a base in a solvent consisting of: (a) methanol and/or ethanol; and (b) optionally water. Also disclosed is a process which comprises isolating erlotinib hydrochloride as its form A polymorph, wherein the form A polymorph exhibits an X-ray powder diffraction (XRPD) pattern comprising at least the characteristic peaks 5.6, 9.8, 18.9, 22.7 and 23.5 ±0.2 degrees 2theta.
Patent NZ-614394-A (NZ)
Title: Biodegradable polymer blend
Inventor: BAILEY PETER BRADBY SPIROS
IPC: C08L67/04
Filed: 2012-03-09
Abstract: Disclosed herein is a biodegradable polymer blend comprising: (i) not less than 70% by weight of poly lactic acid; (ii) between 0.5% to 15% by weight of a first polyester having an average molecular weight of not more than 40,000 and a melt flow rate of greater than 7g/10 mins with 2.16kg at 80°C wherein the first polyester comprises polycaprolactone (PCL) or a linear polyhydroxy alkanoate (PHA); and (iii) between 0.5% to 15% by weight of a second polyester having an average molecular weight greater than that of the first polyester and a melt flow rate less than the first polyester wherein the second polyester comprises: polybutylene succinate (PBS), polycaprolactone (PCL), polybutylene succinate adipate (PBSA), polybutylene adipate (PBA), or polybutylene adipate terephthalate (PBAT). This fully degradable and a compostable polyester based blend is free from non- degradable organic or inorganic additives such as nucleating agents and the like. The thermal properties of the present blend are configured for optimised flow rate during process moulding via a ‘flow rate enhancing component’ being a relative low molecular weight biodegradable polyester. The blend also provides a resultant moulded article having the appropriate mechanical, physical and chemical properties including greatly improved toughness over existing PLA based blends. This is achieved by incorporating a ‘toughening component’ within the blend being a relatively high molecular weight component relative to the flow rate enhancing component.
Patent NZ-709754-A (NZ)
Title: Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
Inventor: LAI JIN-WANG
IPC: A61K9/50
Filed: 2005-10-21
Abstract: The disclosure relates to a pharmaceutical composition comprising a plurality of taste-masked particles, wherein the task-masked particles comprise: (a) a drug-containing core particle; and (b) a taste-masking membrane on said drug-containing core particle comprising a combination of a water-insoluble polymer and a gastrosoluble inorganic or organic pore-former at a ratio ranging from about 85/15 to about 65/15 wherein the composition exhibits acceptable taste-masking when the composition is placed in the oral cavity for 60 seconds and the composition releases not less than about 60% of the dose in 30 min when tested for dissolution using United States Pharmacopoeia Apparatus 2 (paddles at the rate of 50 rpm in 900 mL of pH 1.2 buffer); and (2) a plurality of rapidly-dispersing microgranules with an average particle size of not more than about 400 µm comprising (i) a sugar alcohol or a saccharide or a combination thereof and (ii) a disintegrant, each having an average particle diameter of not more than about 30 µm, wherein the ratio of said sugar alcohol, saccharide or combination thereof to said disintegrant in the rapidly-dispersing microgranules is from about 90/10 to about 99/10.
Patent NZ-712763-A (NZ)
Title: Methods and treatment for certain demyelination and dysmyelination-based disorders and/or promoting remyelination
Inventor: ZHANG ZHONGYAN
IPC: A61K9/14
Filed: 2014-05-08
Abstract: The invention relates to methods and compositions for treating demyelination and/or dysmyelination and/or promoting remyelination of neurons and/or preventing the development of myelin-related diseases by administering to a subject in need thereof an effective amount (either therapeutic or prophylactic) of an elemental gold crystal nanosuspension.
Patent NZ-713679-A (NZ)
Title: Pyridone derivatives for the treatment of viral infections and further diseases
Inventor: RABOISSON PIERRE JEAN-MARIE BERNARD
IPC: A61K31/506
Filed: 2014-05-23
Abstract: This invention relates to pyridone derivatives, processes for their preparation, phamaceutical compositions, and their use in therapy. In particular, the present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, solvate or polymorph thereof, wherein R1 is C1-6 alkyl, optionally substituted by one or more substituents independently selected from aryl, halogen, hydroxyl, amino, carboxylic acid, carboxylic ester, carboxylic amide, acyl sulfonamide, C1-3 alkyl, C3-6 cycloalkyl, sulfone, sulfoxide, sulfonamide, heterocycle or nitrile; R2, R3, R4, and R5 are independently selected from hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy, C3-6 cycloalkyl, aryl, -CF3 or heterocycle; or wherein R2 is fused with R3 to form a 5 to 7-membered saturated or partially saturated monocyclic ring structure, R3 is fused with R4 to form a 5 to 7-membered saturated or partially saturated monocyclic ring structure or R4 is fused with R5 to form a 5 to 7-membered saturated or partially saturated monocyclic ring structure.
Patent NZ-720568-A (NZ)
Title: Wind turbine comprising a segmented tower and foundation
Inventor: KRAFT MARTIN
IPC: E04H12/18
Filed: 2014-12-04
Abstract: The present invention seeks to provide a wind turbine with a foundation, and a tower of a wind turbine which has an improved connection between the tower and the foundation. To achieve an improved connection, the present invention includes a tower, having multiple tower segments, placed on the foundation. The foundation has a tower base which is at least partially cast in the foundation. The tower base has at least two segments; wherein a lower tower segment of the tower is tensioned together with the at least two segments of the tower base, via continuous tensioning rods. The continuous tensioning rods tension together an upper segment of the at least two tower base segments and a flange of the lower tower segment. The upper segment and the at least two segments of the tower base each have through holes for receiving the continuous tensioning rods.
Patent NZ-720775-A (NZ)
Title: Crp resistance blade heating
Inventor: CLEMENS CHRISTIAN
Filed: 2013-08-06
Abstract: The invention relates to a heatable rotor blade (1) of a wind power installation (100) comprising a heating device (33) for heating the rotor blade (1), arranged in the the area of the rotor blade surface. In the past it has been difficult to target the heating performance along the length of the rotor blade. According to the present invention the heating device (33) has electrically conductive heating wires (2), and the heating wires (2) run in a sinusoidal, wave-like and/or zigzag-shaped way, with an amplitude, defining a sinusoidal amplitude, wave height or respectively spike height, and a wavelength defining a period length, wavelength or respectively a distance between spikes, wherein the amplitude and/or wavelength varies along the heating wires (2) in order to be able to adjust the specific areal heating performance of the heating device (33) for each section of blade.